| Supriya Lifescience Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543434 |
NSE Symbol : SUPRIYA |
P/E(TTM) : 32.91 |
|
ISIN Demat : INE07RO01027 |
Div & Yield% : 0.13 |
EPS(TTM) : 22.66 |
|
Book Value(₹) : 134.41 |
Market Cap(₹Cr) : 6,002.81 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 199.83 | 145.07 | 184.11 | 185.65 | 166.10 | 160.63 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 199.83 | 145.07 | 184.11 | 185.65 | 166.10 | 160.63 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.73 | 2.67 | 2.98 | 2.10 | 2.52 | 2.22 |
| Total Income | 202.56 | 147.75 | 187.08 | 187.75 | 168.62 | 162.85 |
| Total Expenditure | 127.19 | 93.37 | 116.53 | 119.70 | 101.39 | 98.09 |
| PBIDT | 75.37 | 54.38 | 70.56 | 68.05 | 67.24 | 64.77 |
| Interest | 0.42 | 0.51 | 0.42 | 0.51 | 0.43 | 0.34 |
| PBDT | 74.96 | 53.86 | 70.14 | 67.54 | 66.81 | 64.43 |
| Depreciation | 6.64 | 6.45 | 6.08 | 4.96 | 4.74 | 4.66 |
| Tax | 15.16 | 10.54 | 12.77 | 13.77 | 15.45 | 14.67 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 2.73 | 2.09 | 0.91 | 2.03 | 0.47 | 0.46 |
| Reported Profit After Tax | 50.43 | 34.79 | 50.38 | 46.78 | 46.15 | 44.64 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 50.43 | 34.79 | 50.38 | 46.78 | 46.15 | 44.64 |
| EPS (Unit Curr.) | 6.27 | 4.32 | 6.29 | 5.82 | 5.71 | 5.54 |
| EPS (Adj) (Unit Curr.) | 6.27 | 4.32 | 6.29 | 5.82 | 5.71 | 5.54 |
| Calculated EPS (Unit Curr.) | 6.27 | 4.32 | 6.26 | 5.81 | 5.73 | 5.55 |
| Calculated EPS (Adj) (Unit Curr.) | 6.27 | 4.32 | 6.26 | 5.81 | 5.73 | 5.55 |
| Calculated EPS (Ann.) (Unit Curr.) | 25.06 | 17.29 | 25.04 | 23.25 | 22.94 | 22.19 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 25.06 | 17.29 | 25.04 | 23.25 | 22.94 | 22.19 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 16.10 | 16.10 | 16.10 | 16.10 | 16.10 | 16.10 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 37.72 | 37.49 | 38.32 | 36.65 | 40.48 | 40.32 |
| PBDTM(%) | 37.51 | 37.13 | 38.10 | 36.38 | 40.22 | 40.11 |
| PATM(%) | 25.24 | 23.98 | 27.36 | 25.20 | 27.78 | 27.79 |